Advertisement Press Releases Archive - Page 159 of 233 - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Pressreleases

  • Meet Biovian at Lyckad Läkemedelsutveckling in Stockholm

    Meet Biovian at 'Lyckad Läkemedelsutveckling' seminar on 31 May 2012 at Hotel Grand, Stockholm, Sweden. Biovian's Director of Business Development and Projects, Dr Knut Ringbom will be available for in-depth disussions with delegates at Biovian's stand.

  • Strength of Aptalis Pharmaceutical Technologies Patents Confirmed by AMRIX® Verdict

    Aptalis Pharmatech, Inc. (previously known as Eurand, Inc.) and Cephalon, Inc. a wholly-owned subsidiary of Teva Pharmaceuticals Industries Ltd, and Anesta AG prevailed in their appeal to the U.S. Court of Appeals for the Federal Circuit which reversed a lower court’s determination and held that two patents covering the AMRIX® muscle relaxant (Cyclobenzaprine Hydrochloride Extended-Release Capsules) are valid.

  • SHL to Speak & Exhibit at the PDA’s Upcoming Prefilled Syringe Seminar in Japan

    Auto injectors have proven to be one of the most convenient and safe methods for patients to self-administer their injections. This trend has become even more noticeable as the number of combination products coming to market continues to increase and biopharmaceutical companies seek to diversify the range of drug delivery options for their products. To support this growth, auto injectors must continue to evolve in both design and functionality.

  • Watson-Marlow Flexicon equipment automates diagnostic operations at Lab21

    Lab21 has installed two semi-automatic Flexicon FF series tabletop filling machines from Watson-Marlow to both improve accuracy and relieve repetitive manual operations at two diagnostic product facilities in Suffolk. The investment allows this progressive and growing company to better support screening and diagnostic laboratories with technically advanced diagnostic products.

  • SOTAX provides new UV-Vis online solutions

    To strengthen its existing UV-Vis portfolio, SOTAX is pleased to announce a new UV-Vis option: the SOTAX SPECORD® PLUS, powered by Analytik Jena. The SPECORD® PLUS conforms to all international pharmacopeias and fulfills the requirements for equipment qualification in the pharmaceutical industry.